KALV — Kalvista Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Kalvista Pharmaceuticals, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2019 April 30th	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	101	67.7	249	166	149
Net Total Receivables	11.3	16.5	10.4	14.1	18.6
Prepaid Expenses
Total Current Assets	116	88.7	264	194	172
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.41	3.65	7.55	10	10.8
Other Long Term Assets
Total Assets	118	92.5	272	204	183
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.1	7.72	9.77	11.6	15
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.4	8.78	14.8	18.8	22.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	96.7	83.8	257	185	161
Total Liabilities & Shareholders' Equity	118	92.5	272	204	183
Total Common Shares Outstanding